Fidelity's passive stake remained at 9.9% with a modest share count increase, consistent with routine portfolio adjustments. No change in ownership level or filing type suggests no imminent activist or strategic shift. Monitor next 13F for broader institutional positioning.
ARGX drugs
ARGX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $894.77entry
- T+1 · 11d ago +3.63%α +3.31% · $927.21
- T+5 · 5d ago +9.67%α +6.38% · $981.33
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 6,178,792 shares of ARGENX SE common stock as of September 30, 2026, representing 9.9% of shares outstanding. This is an increase from the prior filing (March 31, 2026) which reported 5,962,639.48 shares at 9.9%, the share count rose by approximately 216,153 shares, but the percentage remained unchanged at 9.9%, suggesting the increase was proportional to share count changes or a modest net buy. As a passive institutional holder updating a routine 13G, this filing is neutral.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 6,178,792 shares of ARGENX SE common stock as of September 30, 2026.
- The stake represents 9.9% of shares outstanding, unchanged from the prior filing.
- The prior filing (March 31, 2026) reported 5,962,639.48 shares, also at 9.9%.
- The filing is a passive Schedule 13G/A, not a 13D, indicating no activist intent.
- Fidelity Management & Research Company LLC is the entity that beneficially owns 5% or greater of the outstanding shares.
Financial Impact
FMR LLC's stake increased by approximately 216,153 shares (from ~5.96M to ~6.18M), with the percentage unchanged at 9.9%.
Risk Factors
- No material risks identified from this routine passive stake update.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002690 |
| Document: 0000315066-26-002690-index-headers.html | 0000315066-26-002690 |
| Document: 0000315066-26-002690-index.html | 0000315066-26-002690 |
| Document: 0000315066-26-002690.txt | 0000315066-26-002690 |
Track record
23 reports on ARGX
7 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +30.22% at T+60 after the Jun 3, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 9, 20267d ago 6-K Bullish 6/10 Entry $962.27 Now $950.95 −1.18% settles Dec 8
- Nov 9, 20267d ago 6-K Neutral 5/10 Entry $962.27 Now $950.95 −1.18% settles Dec 8
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $962.27 Now $950.95 −1.18% settles Dec 8
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $894.77 Now $950.95 +6.28% settles Dec 4
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $897.85 Now $950.95 +5.91% settles Nov 27
- Oct 22, 202625d ago 6-K Bullish 6/10 Entry $875.76 Now $950.95 +8.59% settles Nov 19
- Oct 19, 202628d ago 6-K Bullish 7/10 Entry $825.61 to $950.95 Now $950.95 +15.18% ▲ +15.18% +18.64% vs SPY
- Oct 8, 20265w ago 6-K Mixed 6/10 Entry $818.63 to $931.38 Now $950.95 +16.16% ▲ +13.77% +19.06% vs SPY
- Sep 29, 20266w ago 6-K Bullish 6/10 Entry $970.66 to $871.52 Now $950.95 −2.03% ▼ −10.21% −10.87% vs SPY
- Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $984.04 to $818.63 Now $950.95 −3.36% ▼ −16.81% −18.93% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers